How does ibuprofen help with PDA?

How Ibuprofen Helps Close a Patent Ductus Arteriosus

When a baby is born, a small blood vessel called the ductus arteriosus—which connects the pulmonary artery to the aorta—normally closes shortly after birth. However, in some infants, especially those born prematurely, this vessel remains open. This condition is known as a patent ductus arteriosus (PDA), and it can lead to breathing difficulties, heart strain, and poor growth if left untreated.

One effective treatment option for closing a PDA is ibuprofen. While commonly known as a pain reliever and anti-inflammatory medication, ibuprofen plays a crucial role in neonatal care. Its mechanism of action lies in its ability to inhibit prostaglandins, hormone-like substances that help keep the ductus arteriosus open during fetal life. By blocking prostaglandin activity, ibuprofen promotes the natural closure of the vessel.

Clinical studies have shown that ibuprofen is just as effective as indomethacin—a drug traditionally used for PDA closure—but with a more favorable side effect profile. This makes it a preferred choice in many neonatal intensive care units. The treatment is typically administered intravenously in a hospital setting, where the infant can be closely monitored.

While not all PDAs require medical intervention—some close on their own—ibuprofen offers a safe and effective pharmacological solution when needed. It’s a prime example of how a well-understood medication can be repurposed to meet the delicate needs of premature infants, helping them on the path to stronger, healthier development.